sermorelin-peptide-studies The FOXO4-DRI senolytic peptide is a cutting-edge therapeutic agent that selectively targets and eliminates senescent cells, a key factor in cellular aging and age-related diseases.Senolytic Peptide FOXO4-DRI Selectively Removes ... - PubMed By disrupting the interaction between FOXO4 and p53, this cell-permeable peptide induces apoptosis (programmed cell death) specifically in senescent cells, leaving healthy cells unharmed. This targeted approach offers a promising avenue for promoting healthier tissue regeneration and potentially mitigating the effects of aging.FOXO4-DRI alleviates age-related testosterone secretion ...
Cellular senescence is a state where cells stop dividing but remain metabolically active, often accumulating in tissues with age. These "zombie cells" secrete a cocktail of inflammatory molecules, proteases, and growth factors known as the Senescence-Associated Secretory Phenotype (SASP), which can damage surrounding tissues and contribute to chronic inflammation, fibrosis, and various age-related conditions.FOXO4-DRIis a cell-permeablepeptideantagonist that blocks the interaction ofFOXO4and p53.FOXO4-DRIis asenolytic peptidethat induces apoptosis of ...
FOXO4 is a transcription factor that plays a crucial role in cellular stress responses and survival.Senolytic Peptide FOXO4-DRISelectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes. Autologous chondrocyte implantation (ACI) is a ... In senescent cells, FOXO4 can accumulate and interact with the tumor suppressor protein p53. This interaction is vital for maintaining the senescent stateFOXO4-DRI - (CAS 2460055-10-9) - Peptides. The FOXO4-DRI peptide acts as an antagonist, effectively blocking the FOXO4-p53 interaction. By doing so, it disrupts the survival signals in senescent cells, triggering their self-destruction through apoptosisFOX04-DRI (10mg Vial) Dosage Protocol. This mechanism is distinct from many other senolytic compounds, highlighting the specificity of FOXO4-DRI.
The FOXO4-DRI peptide's ability to induce apoptosis in senescent cells has garnered significant research interest, particularly for its potential applications in various age-related conditions. Studies have demonstrated its efficacy in:
* Fibroblast Apoptosis: FOXO4-DRI has been shown to induce apoptosis in senescent fibroblasts, including those found in keloids, suggesting a role in wound healing and tissue remodeling.
* Cartilage Regeneration: Research indicates that FOXO4-DRI can remove senescent cells from in vitro expanded human chondrocytes. This could have implications for conditions affecting joint health and cartilage formation.
* Testicular Health: In naturally aged mice, FOXO4-DRI has been observed to improve the testicular microenvironment and alleviate age-related testosterone secretion insufficiency, pointing to potential benefits for reproductive health in aging individuals.Senolytic Peptide Foxo4-Dri Selectively Removes Senescent ...
* Cancer Cell Elimination: Some studies suggest that FOXO4-DRI can act as a senolytic for eliminating senescent human cancer cells, both in cell culture and in animal models. This could complement traditional cancer therapies by targeting senescent cells that may otherwise promote tumor growth or resistance.
The development of FOXO4-DRI as a cell-penetrating peptide antagonist means it can readily enter cells to exert its effects. Its design as a D-retro-inverso (DRI) isoform of FOXO4 is a key innovation, allowing it to specifically target the interaction with p53 without disrupting the normal functions of FOXO4 in healthy cells.
The FOXO4-DRI senolytic peptide represents a significant advancement in the field of senotherapeuticsFOXO4-DRIacetate is a cell-permeablepeptideantagonist that blocks the interaction of FOXO4 and p53.FOXO4-DRIacetate is asenolytic peptidethat induces .... By precisely targeting senescent cells and inducing their removal, it offers a novel strategy for combating cellular aging and its associated pathologies.Senolytic Peptide FOXO4-DRI Selectively Removes ... Ongoing research continues to explore its full therapeutic potential across a range of age-related diseases, from degenerative conditions to inflammatory disorders. As the understanding of cellular senescence deepens, peptides like FOXO4-DRI are poised to play an increasingly important role in promoting longevity and improving healthspan.FOXO4-DRI - MedChem Express
Join the newsletter to receive news, updates, new products and freebies in your inbox.